Search results
Showing 31 to 45 of 247 results for maternity
We are listening to your views on this Technology appraisal guidance. Comments close 30 January 2026.
We are listening to your views on this Technology appraisal guidance. Comments close 3 February 2026.
Upadacitinib for treating giant cell arteritis [ID6299]: draft guidance
We are listening to your views on this Technology appraisal guidance. Comments close 4 February 2026.
We are listening to your views on this Technology appraisal guidance. Comments close 4 February 2026.
We are listening to your views on this NICE guideline. Comments close 27 January 2026.
We are listening to your views on this NICE general. Comments close 30 January 2026.
This indicator covers the proportion of births resulting in a neonatal unit admission. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG36
This indicator covers infant Mortality. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes
This guideline covers how donor milk banks should recruit, screen and support women who donate breast milk. It also covers how milk banks should handle and process the breast milk they receive from donors. It aims to improve the safety of donor milk and operation of donor milk services.
Guidance on the use of electroconvulsive therapy: review proposal consultation
We are listening to your views on this Technology appraisal guidance. Comments close 16 February 2026.
This guideline covers the circumstances for inducing labour, methods of induction, assessment, monitoring, pain relief and managing complications. It aims to improve advice and care for pregnant women who are thinking about or having induction of labour.
We've mapped relevant NICE guidance and advice to NHS England’s Core20PLUS5 for adults
Smoking cessation positively impacts all 5 clinical areas identified by Core20PLUS5 adults.
This quality standard covers recognising, assessing and treating mental health problems in women planning, during or after pregnancy (up to a year after childbirth). It also covers the organisation of mental health services for women during and after pregnancy. It describes high-quality care in priority areas for improvement.
View quality statements for QS115Show all sections
Sections for QS115
- Quality statements
- Quality statement 1: Valproate
- Quality statement 2: Pre-conception information
- Quality statement 3: Information for pregnant women
- Quality statement 4: Asking about mental health and wellbeing
- Quality statement 5: Comprehensive mental health assessment
- Quality statement 6: Psychological interventions
- Quality statement 7 (developmental): Specialist multidisciplinary perinatal mental health services
Our guidelines make evidence based, best practice recommendations. These help to improve patient safety and reduce the risk of harm across the health system.